4 SMID-Cap Biotechs Barclays Just Confessed It Loves

By: via Benzinga
In a new research note, Barclays analysts said that the run in biotech stocks is not over. In fact, the firm initiated coverage on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.